FIELD: pharmaceutics.
SUBSTANCE: group of inventions refers to chemical-pharmaceutical industry. Described two types of vast assemblies compositions for delivery of poorly soluble in medium of gastrointestinal tract drugs. In first version, said composition consists of granules, which comprise: solubility surface-active agent, located around inert substrate; semipermeable coating; medicinal agent particles having effective average size of approximately 2 mqm, located between layer of surface active agent and semi-permeable coating; surface stabiliser adsorbed on surface of drug. Second version of above composition can contain: kernel; surface stabiliser adsorbed on surface of medicinal agent with particle size of approximately 2 mqm; semipermeable coating; solubility agent in form of layer of pH-changing agent, located between layer of medicinal agent and semi-permeable coating.
EFFECT: invention is aimed at improvement of delivery of poorly soluble medicinal agents, having low solubility in medium of gastrointestinal tract.
12 cl, 7 dwg, 7 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
METHODS OF TREATING GASTROINTESTINAL TRACT DISORDERS INDEPENDENTLY ON FOOD CONSUMPTION | 2014 |
|
RU2563993C1 |
ORAL DOSAGE FORMS OF TOFACITINIB WITH CONTINUOUS RELEASE | 2014 |
|
RU2790166C2 |
PHARMACEUTICAL COMPOSITIONS OF METABOTROPIC GLUTAMATE RECEPTOR 5 (MGLU5) ANTAGONISTS | 2011 |
|
RU2602955C2 |
COMPOSITION BASED ON NANOPARTICLES WITH IMPROVED PENETRATION THROUGH MUCOUS MEMBRANES | 2013 |
|
RU2598627C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING DIACEREIN | 2009 |
|
RU2542461C2 |
MEDICINAL CONTROLLED-RELEASING FORMS OF AZITHROMYCIN | 1995 |
|
RU2130311C1 |
TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS | 2014 |
|
RU2674345C2 |
METHODS AND MEDICINAL FORMULATIONS FOR CONTROLLED DELIVERY OF PALIPERIDONE | 2003 |
|
RU2321391C2 |
EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF | 2012 |
|
RU2603471C2 |
ABIRATERONE ACETATE FORMULATION | 2014 |
|
RU2732136C2 |
Authors
Dates
2016-07-10—Published
2010-04-08—Filed